title: Informing patients about phase I trials--how should it be done?
authors.affiliation: Division of Oncology, Ospedale San Giovanni, Bellinzona, Switzerland.
authors.forename: Y
authors.initials: Y
authors.lastname: Willems
authors.forename: C
authors.initials: C
authors.lastname: Sessa
mesh_terms: D004341:Drug Evaluation / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009426:Netherlands; D010353:Patient Education as Topic; D010817:Physician-Patient Relations; D011799:Quinazolines / Q000627:therapeutic use; D012959:Socioeconomic Factors; D013557:Switzerland
chemical_list: D011799:Quinazolines